European Society of Cardiology (ESC) Congress 2012

Top News From ESC 2012: Slideshow
Key trials presented at the sessions include WOEST, FAME II, TRILOGY ACS, ACCESS EU, PURE, and more.

• ESC RE-LY Registry: Wide Variation in AF Management, Mortality
  Heartwire from Medscape, September 6, 2012
• ESC RE-LY Finds Bleeding–Related Gene Variant
  Heartwire from Medscape, September 4, 2012
• ESC Hypertension and Metabolic Syndrome Cut With Workplace Program
  Heartwire from Medscape, August 29, 2012
• ESC 2011 TAVI Patients Were Older But Less Ill Than 2010 Patients
  Heartwire from Medscape, August 29, 2012
• ESC 2.5-mg Rivaroxaban Cuts Cardiac Events in STEM
  Heartwire from Medscape, August 29, 2012
• ESC Apixaban Good for AF Patients With Renal Dysfunction?
  Heartwire from Medscape, August 29, 2012
• ESC Copeptin a Mortality Predictor in High-Risk Systolic HF
  Heartwire from Medscape, August 29, 2012
• ESC AF Ablation Successes, Shortfalls Revealed
  Heartwire from Medscape, August 29, 2012
• ESC CT Can Do Work of SPECT and an Angiogram: CORE320
  Heartwire from Medscape, August 29, 2012
• ESC Positive Results for Renal Denervation Pile up at ESC
  Heartwire from Medscape, August 28, 2012
• ESC Should Platelet Function Be Measured? New Data
  Heartwire from Medscape, August 28, 2012
• ESC Third Universal Definition of MI Is a Charm
  Heartwire from Medscape, August 28, 2012
• ESC FFR-Guided PCI Reduces Urgent Reinterventions
  Heartwire from Medscape, August 28, 2012
• ESC Heart-Failure Spike After Japan Earthquake
  Heartwire from Medscape, August 28, 2012
• ESC Surgical Ablation With Maze Procedure Restores Sinus Rhythm
  Heartwire from Medscape, August 28, 2012
• ESC Drop Aspirin in Stent Patients on Oral Anticoagulants
  Heartwire from Medscape, August 28, 2012
• ESC Treating Diabetic Patients With Insulin Glargine and PUFAs
  Heartwire from Medscape, August 27, 2012
• ESC ESC Issues New Guidelines on Valve Disease
  Heartwire from Medscape, August 27, 2012
• ESC TAVI in-Hospital Death, Stroke Rates Stay Low
  Heartwire from Medscape, August 27, 2012
• ESC Mixed Results for Aldosterone Blockade in Preserved-EF HF
  Heartwire from Medscape, August 27, 2012
• ESC Higher Rates of Myopathy in Chinese Patients: HPS2-THRIVE
  Heartwire from Medscape, August 27, 2012
• ESC No Difference in Stent Thrombosis With Endeavor, Cypher
  Heartwire from Medscape, August 27, 2012
• ESC Heart Rate Linked to Disability, Decline After Stroke
  Heartwire from Medscape, August 27, 2012
• ESC Conflicting MI Trends in Young and Old: FAST-MI
  Heartwire from Medscape, August 27, 2012
• ESC ACCESS-EU: Encouraging Registry Data on Mitraclip
  Heartwire from Medscape, August 27, 2012
• ESC No Survival Benefit of Balloon Pump in AMI With Shock
  Heartwire from Medscape, August 27, 2012
• ESC Spotlight Shifts to Anti-Inflammatories for Cutting CV Risk
  Heartwire from Medscape, August 26, 2012
• ESC New European STEMI Guidelines Emphasize Care Coordination
  Heartwire from Medscape, August 26, 2012
• ESC Merck to Pursue Approval for Vorapaxar in Prior MI Patients
  Heartwire from Medscape, August 26, 2012
• ESC Healthy Lifestyle Factors and Diet Linked With Income: PURE
  Heartwire from Medscape, August 26, 2012
• ESC ALTITUDE: New Data on Why Trial Halted
  Heartwire from Medscape, August 26, 2012
• ESC Dual-Action Agent Shows Promise in Preserved-EF Heart Failure
  Heartwire from Medscape, August 26, 2012
• ESC DeFACTO Study of Noninvasive Fractional Flow Reserve
  Heartwire from Medscape, August 26, 2012
• ESC TRILOGY ACS: Prasugrel Fails to Beat Clopidogrel
  Heartwire from Medscape, August 25, 2012
• ESC No Adverse Effects of E-Cigarettes, But More Research Needed
  Heartwire from Medscape, August 25, 2012
• ESC Many Patients Treated With Statins, Not Many Treated to Target
  Heartwire from Medscape, August 25, 2012
• ESC What's Going to Be Hot at the ESC 2012 Congress
  Heartwire from Medscape, August 21, 2012